FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Published at www.nejm.org June 30, 2009 (10.1056/NEJMp0904133)

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Directed by Congress to rapidly develop a list of broad-based priorities for the Department of Health and Human Services (DHHS) to consider as it implements a new agenda for comparative-effectiveness research (CER), the Institute of Medicine (IOM) released a report recommending a portfolio of 100 study topics related to a range of diseases, research methods, and care models that are important to the health of the U.S. population. The IOM report,¹ released June 30, also recommends research studies on rare diseases that disproportionately affect certain subgroups of the population, such as women, racial or ethnic minorities, and particular age groups. . . . [Full Text of this Article]

Source Information

Mr. Iglehart is a national correspondent for the Journal.

This article (10.1056/NEJMp0904133) was published on June 30, 2009, at NEJM.org.

This article has been cited by other articles:

• Morris, P. E., Munro, C. L. (2009). Will Comparative Effectiveness Research Increase Patient Safety in Intensive Care Units?. Am J Crit Care 18: 504-506 [Full Text]